REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 441 filers reported holding REPLIGEN CORP in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,951,244 | +43.6% | 458,784 | +27.8% | 0.21% | +50.4% |
| Q2 2023 | $50,787,111 | +36.5% | 359,021 | +62.5% | 0.14% | +25.9% |
| Q1 2023 | $37,203,183 | +2455.0% | 220,974 | +2469.5% | 0.11% | +2140.0% |
| Q4 2022 | $1,456,066 | +14.5% | 8,600 | +26.5% | 0.01% | +25.0% |
| Q3 2022 | $1,272,000 | – | 6,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |